Press Releases

Emerging Therapies Explained: Blood test for brain tumours

Hover to Know More

BRAIN TUMOUR RESEARCH

Published on: December, 2023

Read More

Datar Cancer Genetics and Cromwell Hospital’s Second Opinion Service

Hover to Know More

Cromwell Hospital Newsroom

Published on: October, 2023

Read More

US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors

Hover to Know More

CISION PR Newswire

Published on: January, 2022

Read More

'Game Changer' Blood Test Detects Breast Cancer

‘Game-changer’ blood test
detects breast cancer earlier
than X-rays, study shows

Hover to Know More

Independent

Published on: July, 2022

Read More

Landmark Liquid Biopsy Study

Landmark Liquid Biopsy Study Shows Accurate Detection of Early-Stage Breast Cancer
Study establishes the high clinical performance of ‘Trucheck™ - Breast’ blood test.

Hover to Know More

EIN Presswire

Published on: 13 July, 2022

Read More

The London Clinic News

Datar Cancer Genetics enters into partnership with The London Clinic to offer enhanced cancer testing services

Hover to Know More

EIN Presswire

Published on: 11 Apr, 2022

Read More

FDA News - Prostate Cancer

Datar’s TriNetra-Prostate Blood Test Gets FDA Breakthrough Designation.



Hover to Know More

Precision Medicine

Published on: 14 Feb, 2022

Read More

South Africa - News

Groundbreaking’ high-sensitivity cancer-screening test arriving in SA ahead of World Cancer Day.

Hover to Know More

IOL

Published on: 2 Feb, 2022

Read More

Kuwait - News

Virtus Group announces partnership with Datar Cancer Genetics for personalized precision oncology solutions in Kuwait.

Hover to Know More

Arab Newswire

Published on: 7 Dec, 2021

Read More

FDA News - Breast Cancer

US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics.

Hover to Know More

CISION PR Newswire

Published on: 19 Nov, 2022

Read More

The Healthcare Technology Report

The Top 25 Women Leaders in Biotechnology of 2021 (Swati Deshpande - Datar Cancer Genetics).

Hover to Know More

The Healthcare Technology

Published on: 19 Oct, 2021

Read More

NICE - UK

UK - National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on 'Trublood Prostate' for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a 'Game Changer'.

Hover to Know More

CISION PR Newswire

Published on: 13 Jul, 2021

Read More

Get second opinion now

Please contact on:
+44 (0)20 7460 5586
[email protected]

OR